文献速递骨肌技术与安全MRPETCT

全身DWI与18F-FDG PET/CT检测多发性骨髓瘤髓内及髓外病变的比较

Comparison of Whole-Body DWI and 18F-FDG PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma.
PubMed 文献 · AJR Am J Roentgenol · 2019-06-05

研究纳入49例多发性骨髓瘤患者,比较全身DWI与PET/CT检测髓内及髓外病变的能力。结果显示除颅骨外全身各区域DWI对髓内病变评分均高于PET/CT,新诊断与既往治疗患者均如此;髓外病变检出数目两者无统计学差异。

要点

  • 除颅骨外,全身各区域髓内病变DWI评分均高于PET/CT(p<0.05)。
  • 新诊断与既往治疗患者中,DWI对髓内病变的检出均优于PET/CT。
  • 髓外病变检出数目DWI与PET/CT无统计学差异(4.48 vs 4.39,p=0.86)。

核心结论

  • 检测髓内病变时,除颅骨外全身各区域DWI均比PET/CT更敏感,新诊断与既往治疗患者均如此,在浆细胞比例低的患者中尤为明显;检测髓外病变时DWI敏感性与PET/CT相当;两种方法联用可能提供互补信息。

研究设计与样本

  • 研究纳入49例多发性骨髓瘤患者,均行全身DWI与18F-FDG PET/CT检查。

关键影像表现/征象

  • 采用评分系统分别基于全身DWI和PET/CT对每个区域的髓内病变进行评分。
  • 全身DWI和PET/CT分别记录每例患者的髓外病变。
  • 两种方法均见全脊柱弥漫性病变者定义为A组,仅全身DWI见全脊柱弥漫性病变者定义为B组。

诊断标准与关键数值

  • 除颅骨外全身各区域髓内病变DWI评分均高于PET/CT(p<0.05),新诊断与既往治疗患者均如此。
  • A组浆细胞平均百分比显著高于B组(50.458%±16.036% vs 18.682%±15.524%;p=0.00)。
  • 髓外病变平均检出数目DWI为4.48±6.70个,PET/CT为4.39±6.46个,两者无统计学差异(p=0.86)。

临床应用与阅片要点

  • 阅片时除颅骨外各区域髓内病变可优先参考DWI,其对髓内病变的检出优于PET/CT。
  • 浆细胞比例低的患者中DWI对髓内病变的检出优势尤为明显。
  • 髓外病变检出DWI与PET/CT敏感性相当,两种方法联用可能提供互补信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to compare the ability of whole-body (WB) DWI and 18F-FDG PET/CT in detecting intramedullary and extramedullary lesions in multiple myeloma. MATERIALS AND METHODS. The study included 49 patients with multiple myeloma who had undergone WB DWI and PET/CT. Intramedullary lesions for each region were scored by a scoring system using WB DWI and PET/CT separately. Extramedullary lesions seen separately on WB DWI and PET/CT per patient were recorded. Patients with diffuse lesions of the whole spine seen using both modalities were defined as group A, and those with such lesions seen on WB DWI only were defined as group B. The mean scores assigned to intramedullary lesions using the two modalities, the numbers of extramedullary lesions detected by WB DWI and PET/CT, and the mean percentages of plasma cells in the two patient groups were compared. RESULTS. Scores were higher for WB DWI than for PET/CT in all regions of the body (p < 0.05) except the skull, both in patients with a new diagnosis of multiple myeloma and in previously treated patients. Mean (± SD) percentages of plasma cells were significantly higher in group A than group B (50.458% ± 16.036% vs 18.682% ± 15.524%; p = 0.00). The mean number of extramedullary lesions detected by WB DWI was slightly higher than the mean number detected by PET/CT, although there was no statistical difference (4.48 ± 6.70 vs 4.39 ± 6.46 lesions; p = 0.86). CONCLUSION. For detecting intramedullary lesions, WB DWI is more sensitive than PET/CT in all regions except the skull, both in patients with a new diagnosis and previously treated patients and especially in patients with a low percentage of plasma cells. For detecting extramedullary lesions, WB DWI has sensitivity equivalent to that of PET/CT. The use of both modalities may offer complementary information.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Chen J, Li C, Tian Y, et al. Comparison of Whole-Body DWI and 18F-FDG PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma. AJR Am J Roentgenol. 2019. PMID: 31166755. doi:10.2214/AJR.18.20989

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。